Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 14 studies | 39% ± 18% | |
IgA plasma cell | 9 studies | 65% ± 27% | |
memory B cell | 7 studies | 26% ± 13% | |
B cell | 4 studies | 25% ± 6% | |
IgG plasma cell | 3 studies | 52% ± 25% | |
plasmablast | 3 studies | 37% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 33% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 83% | 6347.88 | 482 / 578 | 77% | 663.75 | 891 / 1155 |
stomach | 74% | 22243.46 | 265 / 359 | 65% | 813.50 | 187 / 286 |
intestine | 57% | 125103.13 | 552 / 966 | 70% | 1145.31 | 371 / 527 |
breast | 48% | 16754.26 | 222 / 459 | 53% | 365.73 | 597 / 1118 |
spleen | 98% | 30802.93 | 235 / 241 | 0% | 0 | 0 / 0 |
pancreas | 22% | 683.75 | 72 / 328 | 69% | 504.46 | 122 / 178 |
esophagus | 28% | 3761.97 | 410 / 1445 | 50% | 452.29 | 92 / 183 |
tonsil | 0% | 0 | 0 / 0 | 73% | 877.01 | 33 / 45 |
peripheral blood | 68% | 6210.66 | 629 / 929 | 0% | 0 | 0 / 0 |
bladder | 19% | 4330.24 | 4 / 21 | 48% | 629.18 | 241 / 504 |
thymus | 21% | 2747.05 | 136 / 653 | 29% | 126.58 | 175 / 605 |
uterus | 9% | 289.18 | 16 / 170 | 39% | 273.02 | 181 / 459 |
kidney | 22% | 2607.34 | 20 / 89 | 23% | 220.66 | 206 / 901 |
prostate | 31% | 1654.38 | 75 / 245 | 14% | 47.65 | 70 / 502 |
liver | 34% | 654.00 | 76 / 226 | 6% | 19.55 | 24 / 406 |
lymph node | 0% | 0 | 0 / 0 | 34% | 100.98 | 10 / 29 |
skin | 9% | 291.39 | 171 / 1809 | 16% | 55.93 | 77 / 472 |
ovary | 8% | 106.22 | 14 / 180 | 10% | 26.70 | 44 / 430 |
adipose | 15% | 446.37 | 180 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 345.26 | 165 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 4% | 94.91 | 11 / 258 | 7% | 24.62 | 17 / 230 |
eye | 0% | 0 | 0 / 0 | 4% | 12.70 | 3 / 80 |
heart | 3% | 56.21 | 26 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 4.27 | 3 / 2642 | 1% | 1.92 | 7 / 705 |
muscle | 0% | 9.57 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003094 | Biological process | glomerular filtration |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_0060267 | Biological process | positive regulation of respiratory burst |
GO_0005615 | Cellular component | extracellular space |
GO_0042571 | Cellular component | immunoglobulin complex, circulating |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0071752 | Cellular component | secretory dimeric IgA immunoglobulin complex |
GO_0071751 | Cellular component | secretory IgA immunoglobulin complex |
GO_0072562 | Cellular component | blood microparticle |
GO_0071748 | Cellular component | monomeric IgA immunoglobulin complex |
GO_0071745 | Cellular component | IgA immunoglobulin complex |
GO_0034987 | Molecular function | immunoglobulin receptor binding |
GO_0003823 | Molecular function | antigen binding |
Gene name | IGHA2 |
Protein name | Immunoglobulin heavy constant alpha 2 Immunoglobulin heavy constant alpha 2 (Ig alpha-2 chain C region) (Ig alpha-2 chain C region BUT) (Ig alpha-2 chain C region LAN) |
Synonyms | |
Description | FUNCTION: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens . The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen . Ig alpha is the major immunoglobulin class in body secretions . . |
Accessions | P01877 ENST00000390539.2 [P01877-1] A0A0G2JMB2 ENST00000497872.4 [P01877-2] ENST00000622473.2 |